USD
+$0.00
(+0.00%
)At Close (As of Sep 3, 2025)
$908.91M
Market Cap
-
P/E Ratio
-11.39
EPS
$25.28
52 Week High
$3.97
52 Week Low
LIFE SCIENCES
Sector
Field | Value (USD) |
---|---|
Gross Profit | $534M |
Total Revenue | $2.7B |
Cost Of Revenue | $2.2B |
Costof Goods And Services Sold | $2.2B |
Operating Income | -$162M |
Selling General And Administrative | $561M |
Research And Development | - |
Operating Expenses | $696M |
Investment Income Net | - |
Net Interest Income | -$124M |
Interest Income | - |
Interest Expense | $124M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $85M |
Income Before Tax | -$275M |
Income Tax Expense | -$3.5M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$272M |
Comprehensive Income Net Of Tax | - |
Ebit | -$150M |
Ebitda | -$64M |
Net Income | -$329M |
Field | Value (USD) |
---|---|
Total Assets | $3.6B |
Total Current Assets | $948M |
Cash And Cash Equivalents At Carrying Value | $119M |
Cash And Short Term Investments | $119M |
Inventory | - |
Current Net Receivables | $694M |
Total Non Current Assets | $2.6B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $656M |
Intangible Assets Excluding Goodwill | $656M |
Goodwill | $1.7B |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $136M |
Other Non Current Assets | - |
Total Liabilities | $2.2B |
Total Current Liabilities | $950M |
Current Accounts Payable | $138M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $88M |
Total Non Current Liabilities | $1.3B |
Capital Lease Obligations | $74M |
Long Term Debt | $1B |
Current Long Term Debt | $75M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.2B |
Other Current Liabilities | $317M |
Other Non Current Liabilities | $35M |
Total Shareholder Equity | $1.4B |
Treasury Stock | - |
Retained Earnings | -$397M |
Common Stock | $100K |
Common Stock Shares Outstanding | $90M |
Field | Value (USD) |
---|---|
Operating Cashflow | $263M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $98M |
Capital Expenditures | $26M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $252M |
Cashflow From Financing | -$498M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$329M |
Field | Value (USD) |
---|---|
Gross Profit | $534M |
Total Revenue | $2.7B |
Cost Of Revenue | $2.2B |
Costof Goods And Services Sold | $2.2B |
Operating Income | -$162M |
Selling General And Administrative | $561M |
Research And Development | - |
Operating Expenses | $696M |
Investment Income Net | - |
Net Interest Income | -$124M |
Interest Income | - |
Interest Expense | $124M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $85M |
Income Before Tax | -$275M |
Income Tax Expense | -$3.5M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$272M |
Comprehensive Income Net Of Tax | - |
Ebit | -$150M |
Ebitda | -$64M |
Net Income | -$329M |
Sector: LIFE SCIENCES
Industry: SERVICES-MEDICAL LABORATORIES
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. The company is headquartered in Durham, North Carolina.